These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17181934)

  • 1. Cyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG/PRINTO phase IV post marketing surveillance study.
    Ruperto N; Ravelli A; Castell E; Gerloni V; Haefner R; Malattia C; Kanakoudi-Tsakalidou F; Nielsen S; Bohnsack J; Gibbas D; Rennebohm R; Voygioyka O; Balogh Z; Lepore L; Macejkova E; Wulffraat N; Oliveira S; Russo R; Buoncompagni A; Hilário MO; Alpigiani MG; Passo M; Lovell DJ; Merino R; Martini A; Giannini EH; ;
    Clin Exp Rheumatol; 2006; 24(5):599-605. PubMed ID: 17181934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis.
    Ravelli A; Moretti C; Temporini F; Rossi F; Magni-Manzoni S; Pistorio A; Martini A
    Clin Exp Rheumatol; 2002; 20(4):569-72. PubMed ID: 12175118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.
    Verazza S; Davì S; Consolaro A; Bovis F; Insalaco A; Magni-Manzoni S; Nicolai R; Marafon DP; De Benedetti F; Gerloni V; Pontikaki I; Rovelli F; Cimaz R; Marino A; Zulian F; Martini G; Pastore S; Sandrin C; Corona F; Torcoletti M; Conti G; Fede C; Barone P; Cattalini M; Cortis E; Breda L; Olivieri AN; Civino A; Podda R; Rigante D; La Torre F; D'Angelo G; Jorini M; Gallizzi R; Maggio MC; Consolini R; De Fanti A; Muratore V; Alpigiani MG; Ruperto N; Martini A; Ravelli A;
    Pediatr Rheumatol Online J; 2016 Dec; 14(1):68. PubMed ID: 27993144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longterm prospective real-life experience with leflunomide in juvenile idiopathic arthritis.
    Alcântara AC; Leite CA; Leite AC; Sidrim JJ; Silva FS; Rocha FA
    J Rheumatol; 2014 Feb; 41(2):338-44. PubMed ID: 24334641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan.
    Mori M; Takei S; Imagawa T; Imanaka H; Nerome Y; Higuchi R; Kawano Y; Yokota S; Sugiyama N; Yuasa H; Fletcher T; Wajdula JS
    Mod Rheumatol; 2012 Sep; 22(5):720-6. PubMed ID: 22212889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A follow-up study of patients with juvenile idiopathic arthritis who discontinued etanercept due to disease remission.
    Pratsidou-Gertsi P; Trachana M; Pardalos G; Kanakoudi-Tsakalidou F
    Clin Exp Rheumatol; 2010; 28(6):919-22. PubMed ID: 21205467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of methotrexate in children with rheumatic diseases.
    Gutiérrez-Suárez R; Burgos-Vargas R
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
    Horton DB; Onel KB; Beukelman T; Ringold S
    J Rheumatol; 2017 Mar; 44(3):352-360. PubMed ID: 28148696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop?
    Foell D; Frosch M; Schulze zur Wiesch A; Vogl T; Sorg C; Roth J
    Ann Rheum Dis; 2004 Feb; 63(2):206-8. PubMed ID: 14722212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry.
    Foeldvari I; Becker I; Horneff G
    Arthritis Care Res (Hoboken); 2015 Nov; 67(11):1529-35. PubMed ID: 25988824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
    Giancane G; Lavarello C; Pistorio A; Oliveira SK; Zulian F; Cuttica R; Fischbach M; Magnusson B; Pastore S; Marini R; Martino S; Pagnier A; Soler C; Staņēvicha V; Ten Cate R; Uziel Y; Vojinovic J; Fueri E; Ravelli A; Martini A; Ruperto N;
    Pediatr Rheumatol Online J; 2019 May; 17(1):24. PubMed ID: 31118099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study.
    Horneff G; Foeldvari I; Minden K; Trauzeddel R; Kümmerle-Deschner JB; Tenbrock K; Ganser G; Huppertz HI
    Arthritis Rheumatol; 2015 May; 67(8):2240-9. PubMed ID: 25891010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study.
    Drosos AA; Voulgari PV; Papadopoulos IA; Politi EN; Georgiou PE; Zikou AK
    Clin Exp Rheumatol; 1998; 16(6):695-701. PubMed ID: 9844762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept.
    Katsicas MM; Russo RA
    Clin Exp Rheumatol; 2005; 23(4):545-8. PubMed ID: 16095128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.
    Otten MH; Prince FH; Armbrust W; ten Cate R; Hoppenreijs EP; Twilt M; Koopman-Keemink Y; Gorter SL; Dolman KM; Swart JF; van den Berg JM; Wulffraat NM; van Rossum MA; van Suijlekom-Smit LW
    JAMA; 2011 Dec; 306(21):2340-7. PubMed ID: 22056397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry.
    Lovell DJ; Tzaribachev N; Henrickson M; Simonini G; Griffin TA; Alexeeva E; Bohnsack JF; Zeft A; Horneff G; Vehe RK; Staņēviča V; Tarvin S; Trachana M; Del Río AQ; Huber AM; Kietz D; Orbán I; Dare J; Foeldvari I; Quartier P; Dominique A; Simon TA; Martini A; Brunner HI; Ruperto N;
    Rheumatology (Oxford); 2024 Sep; 63(SI2):SI195-SI206. PubMed ID: 38243722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
    Kostik MM; Gaidar EV; Hynnes AY; Dubko MF; Masalova VV; Snegireva LS; Chikova IA; Isupova EA; Nikitina TN; Serogodskaya ED; Kalashnikova OV; Ravelli A; Chasnyk VG
    Clin Exp Rheumatol; 2016; 34(4):714-8. PubMed ID: 27385618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
    Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
    Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etanercept in systemic juvenile idiopathic arthritis.
    Russo RA; Katsicas MM; Zelazko M
    Clin Exp Rheumatol; 2002; 20(5):723-6. PubMed ID: 12412209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of juvenile idiopathic arthritis exhibiting repair of systemic bone erosion in response to continuation of MTX therapy after achievement of clinical remission.
    Nakatani T; Maekawa T; Ishii S
    Mod Rheumatol; 2011 Oct; 21(5):514-7. PubMed ID: 21331659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.